Your browser version may not work well with NCBI's Web applications. More information here...
1: Neth J Med. 2004 Feb;62(2):45-52.Click here to read Links

Prevention of infections in hyposplenic and asplenic patients: an update.

Department of Medical Microbiology & Infectious Diseases, Infectious Diseases Section, Erasmus University Medical Centre, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. d.melles@eramusmc.nl

Patients with functional or anatomic asplenia are at a significantly increased risk of overwhelming infection, particularly involving the encapsulated bacteria Streptococcus pneumoniae and Haemophilus influenzae. The risk is highest in infants and young children, but adults also have an increased risk of infection. Preventive strategies are very important and fall into three major categories: immunoprophylaxis, antibiotic prophylaxis and education. Studies have shown that many asplenic patients are unaware of their increased risk for serious infection and the appropriate health precautions that should be undertaken. In this article we emphasise the need for preventive measures in hyposplenic and asplenic patients. We discuss the value of newly developed conjugate vaccines and the need for revaccination. Finally we draw up a recommendation for the preventive management in functional and anatomical asplenic patients.

PMID: 15127830 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Pneumococcal Polysaccharide Vaccine (Pneumovax® 23)

    Pneumococcal disease is caused byStreptococcus pneumoniae bacteria. It is a leading cause of vaccine-preventable illness and death in the United States. Anyone can get pneumococcal disease, but some people are at greater...

  • Pneumococcal Conjugate Vaccine (Prevnar® )

    Infection withStreptococcus pneumoniae bacteria can cause serious illness and death. Invasive pneumococcal disease is responsible for about 200 deaths each year among children under 5 years old. It is the leading cause o...